Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FOD Capital is a family office investment fund based in Key West, Florida, founded in 2017 by Donald Foss and Michael Raymond. The firm specializes in identifying and executing entrepreneurial and opportunistic investments across a wide range of sectors, with a significant emphasis on life sciences, healthcare, and disruptive technologies. FOD Capital's investment strategy often involves providing structured secured bridge debt with equity components, targeting growth-stage companies that possess experienced management and large exploitable markets. Their healthcare-related portfolio includes notable investments in biotechnology companies like EdenRoc Sciences and digital health platforms such as Amwell. The firm is known for its hands-on leadership approach and its ability to partner with unique companies to drive long-term value.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on FOD Capital.